107 related articles for article (PubMed ID: 23562091)
21. Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.
Pilla SJ; Quan AQ; Germain-Lee EL; Hellmann DB; Mathioudakis NN
Curr Diab Rep; 2016 Oct; 16(10):91. PubMed ID: 27525682
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.
Galeotti C; Meinzer U; Quartier P; Rossi-Semerano L; Bader-Meunier B; Pillet P; Koné-Paut I
Rheumatology (Oxford); 2012 Oct; 51(10):1855-9. PubMed ID: 22740624
[TBL] [Abstract][Full Text] [Related]
23. [Biological therapy treatment of juvenile idiopathic arthritis].
Herlin T
Ugeskr Laeger; 2008 Jun; 170(24):2105-8. PubMed ID: 18565289
[TBL] [Abstract][Full Text] [Related]
24. Actual status of antiinterleukin-1 therapies in rheumatic diseases.
Geyer M; Müller-Ladner U
Curr Opin Rheumatol; 2010 May; 22(3):246-51. PubMed ID: 20150813
[TBL] [Abstract][Full Text] [Related]
25. Time for testing incretin therapies in early type 1 diabetes?
Bosi E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2607-9. PubMed ID: 20525907
[TBL] [Abstract][Full Text] [Related]
26. [Antibodies instead of insulin?].
Anders S; Kühnemund L; Stauch M; Zündorf I; Dingermann T
Pharm Unserer Zeit; 2010 Mar; 39(2):97-8. PubMed ID: 20196056
[No Abstract] [Full Text] [Related]
27. Improving type 1 diabetes after treatment of immune thrombocytopenia with rituximab: killing two birds with one stone.
Quintana L; Paniagua JA; Gil-Contreras D; Jimenez-Yuste V; Torres A; Velasco F
Diabetes Care; 2010 Sep; 33(9):e122. PubMed ID: 20805264
[No Abstract] [Full Text] [Related]
28. Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response.
Gibbons LJ; Hyrich KL
BioDrugs; 2009; 23(2):111-24. PubMed ID: 19489652
[TBL] [Abstract][Full Text] [Related]
29. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
Shekhar C
Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
[No Abstract] [Full Text] [Related]
30. Combination therapies for type 1 diabetes: why not now?
von Herrath M
Immunotherapy; 2010 May; 2(3):289-91. PubMed ID: 20635894
[No Abstract] [Full Text] [Related]
31. Familial Mediterranean fever patients may have unmet needs for treatment of erysipelas-like erythema.
Tezcan ME
Clin Exp Rheumatol; 2017; 35 Suppl 104(2):9. PubMed ID: 27782864
[No Abstract] [Full Text] [Related]
32. ATG in type 1 diabetes: an unanswered question.
Skyler JS
Lancet Diabetes Endocrinol; 2013 Dec; 1(4):265-6. PubMed ID: 24622406
[No Abstract] [Full Text] [Related]
33. Metformin in type 1 diabetes mellitus? Revisiting treatment dogmas in diabetes.
Klupa T
Pol Arch Med Wewn; 2016 Aug; 126(7-8):461-2. PubMed ID: 27578217
[No Abstract] [Full Text] [Related]
34. Type 2 treatments for type 1 diabetes.
Bloomgarden Z; Ning G
J Diabetes; 2016 Sep; 8(5):599-601. PubMed ID: 27206987
[No Abstract] [Full Text] [Related]
35. Diabetes mellitus. Through the ages.
Borthwick LJ
Nurs Mirror; 1980 Oct; 151(18):26-9. PubMed ID: 7001385
[No Abstract] [Full Text] [Related]
36. Glycemic treatment in type 1 and type 2 diabetes.
Bloomgarden ZT
Diabetes Care; 2006 Nov; 29(11):2549-55. PubMed ID: 17065700
[No Abstract] [Full Text] [Related]
37. Targeting innate immunity for treatment of type 1 diabetes.
Bednar KJ; Ridgway WM
Immunotherapy; 2014; 6(12):1239-42. PubMed ID: 25524380
[No Abstract] [Full Text] [Related]
38. Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.
Sacré K; Brihaye B; Lidove O; Papo T; Pocidalo MA; Cuisset L; Dodé C
J Rheumatol; 2008 Feb; 35(2):357-8. PubMed ID: 18260167
[No Abstract] [Full Text] [Related]
39. [Effect of the use of diformin in a patient with diabetes mellitus type I with hyperlipidemia].
Antsiferov MB; Starostina EG
Probl Endokrinol (Mosk); 1988; 34(5):42-3. PubMed ID: 3217387
[No Abstract] [Full Text] [Related]
40. Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome.
Moosig F; Gross WL; Herrmann K; Bremer JP; Hellmich B
Ann Intern Med; 2011 Sep; 155(5):341-3. PubMed ID: 21893636
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
